Ancora Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.4M Sell
229,968
-21,326
-8% -$4.97M 1.13% 16
2026
Q1
$61.4M Sell
251,294
-25,693
-9% -$5.98M 1.31% 13
2025
Q4
$57.3M Buy
276,987
+1,085
+0.4% +$215K 1.18% 14
2025
Q3
$51.2M Buy
275,902
+12,361
+5% +$2.12M 1.02% 19
2025
Q2
$40.3M Buy
263,541
+1,507
+0.6% +$232K 0.84% 26
2025
Q1
$43.5M Buy
262,034
+1,335
+0.5% +$209K 0.97% 23
2024
Q4
$37.7M Sell
260,699
-8,867
-3% -$1.37M 0.84% 24
2024
Q3
$43.7M Sell
269,566
-13,628
-5% -$2.17M 0.99% 21
2024
Q2
$41.4M Buy
283,194
+1,987
+0.7% +$296K 1.03% 22
2024
Q1
$44.5M Sell
281,207
-18,715
-6% -$2.98M 1.01% 22
2023
Q4
$47M Sell
299,922
-6,326
-2% -$970K 1.1% 19
2023
Q3
$47.7M Sell
306,248
-8,153
-3% -$1.35M 1.27% 17
2023
Q2
$52M Buy
314,401
+4,184
+1% +$675K 1.37% 12
2023
Q1
$48.1M Buy
310,217
+5,960
+2% +$962K 1.36% 15
2022
Q4
$53.7M Buy
304,257
+30,959
+11% +$5.35M 1.55% 9
2022
Q3
$44.6M Buy
273,298
+3,778
+1% +$639K 1.38% 12
2022
Q2
$47.8M Buy
269,520
+3,877
+1% +$691K 1.35% 11
2022
Q1
$47.1M Sell
265,643
-7,294
-3% -$1.24M 1.14% 13
2021
Q4
$46.7M Buy
272,937
+5,583
+2% +$914K 1.11% 15
2021
Q3
$43.2M Buy
267,354
+9,162
+4% +$1.56M 1.12% 11
2021
Q2
$42.5M Sell
258,192
-5,474
-2% -$906K 1.11% 10
2021
Q1
$43.3M Buy
263,666
+6,350
+2% +$1.03M 1.2% 9
2020
Q4
$40.5M Buy
257,316
+2,635
+1% +$389K 1.3% 8
2020
Q3
$37.9M Buy
254,681
+7,877
+3% +$1.17M 1.51% 7
2020
Q2
$34.7M Buy
246,804
+2,962
+1% +$432K 1.45% 7
2020
Q1
$32M Buy
243,842
+15,033
+7% +$2.13M 1.48% 6
2019
Q4
$33.4M Buy
228,809
+35,463
+18% +$4.81M 1.24% 7
2019
Q3
$25M Buy
193,346
+10,155
+6% +$1.34M 1.09% 12
2019
Q2
$25.5M Buy
183,191
+5,354
+3% +$741K 1.14% 7
2019
Q1
$24.9M Buy
177,837
+7,074
+4% +$948K 1.13% 6
2018
Q4
$22M Buy
170,763
+5,417
+3% +$756K 1.06% 9
2018
Q3
$22.8M Buy
165,346
+30,418
+23% +$4.04M 0.88% 11
2018
Q2
$16.4M Buy
134,928
+3,355
+3% +$419K 0.71% 24
2018
Q1
$16.9M Buy
131,573
+19,371
+17% +$2.62M 0.76% 25
2017
Q4
$15.7M Buy
112,202
+2,923
+3% +$407K 0.84% 23
2017
Q3
$14.2M Buy
109,279
+2,881
+3% +$382K 0.82% 20
2017
Q2
$14.1M Sell
106,398
-788
-0.7% -$101K 0.91% 15
2017
Q1
$13.3M Buy
107,186
+172
+0.2% +$20.5K 0.9% 13
2016
Q4
$12.3M Buy
107,014
+43,513
+69% +$5.03M 0.9% 15
2016
Q3
$7.5M Buy
63,501
+1,444
+2% +$175K 0.76% 22
2016
Q2
$7.53M Buy
62,057
+1,493
+2% +$170K 0.88% 17
2016
Q1
$6.55M Buy
60,564
+323
+0.5% +$33.4K 0.8% 22
2015
Q4
$6.19M Sell
60,241
-225
-0.4% -$22.6K 0.79% 23
2015
Q3
$5.64M Buy
60,466
+432
+0.7% +$41.8K 0.73% 25
2015
Q2
$5.85M Buy
+60,034
New +$6.01M 0.69% 31
2015
Q1
Sell
-60,831
Closed -$6.19M 28
2014
Q4
$6.36M Sell
60,831
-1,079
-2% -$114K 0.78% 24
2014
Q3
$6.6M Buy
61,910
+2,533
+4% +$263K 0.85% 22
2014
Q2
$6.21M Buy
59,377
+5,787
+11% +$585K 0.8% 24
2014
Q1
$5.26M Buy
53,590
+3,405
+7% +$316K 0.74% 25
2013
Q4
$4.6M Buy
50,185
+1,450
+3% +$134K 0.69% 32
2013
Q3
$4.22M Buy
48,735
+1,476
+3% +$132K 0.73% 31
2013
Q2
$4.06M Buy
+47,259
New +$4.01M 0.7% 34

Other funds holding JNJ

Ancora Advisors's JNJ Position: Q2 2026 in Review

Ancora Advisors reduced its Johnson & Johnson (JNJ) stake by 8.5% in Q2 2026, selling an estimated $4.97M and leaving 229,968 shares worth $58.4M. The position accounts for 1.13% of the portfolio, ranked #16.

Ancora Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $61.4M in Q1 2026. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Ancora Advisors held 229,968 shares of Johnson & Johnson worth $58.4M as of Q2 2026.
  • Ancora Advisors sold 21,326 Johnson & Johnson shares in Q2 2026, an estimated $4.97M.
  • Johnson & Johnson made up 1.13% of Ancora Advisors's portfolio in Q2 2026, its #16 holding.
  • Ancora Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Ancora Advisors's Johnson & Johnson position peaked at $61.4M in Q1 2026.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.